Related references
Note: Only part of the references are listed.Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
H. Ralph Schumacher et al.
ARTHRITIS AND RHEUMATISM (2012)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Reduction of In Vitro Invasion and In Vivo Cartilage Degradation in a SCID Mouse Model by Loss of Function of the Fibrinolytic System of Rheumatoid Arthritis Synovial Fibroblasts
Simona Serrati et al.
ARTHRITIS AND RHEUMATISM (2011)
Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2011)
Inflammatory Gout: Observations over a Half-Century
Stephen E. Malawista et al.
FASEB JOURNAL (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Gout therapeutics: new drugs for an old disease
Christopher M. Burns et al.
LANCET (2011)
The Epidemiology of Uric Acid and Fructose
Young Hee Rho et al.
SEMINARS IN NEPHROLOGY (2011)
Cross-Sectional Analysis of Foot Function, Functional Ability, and Health-Related Quality of Life in Older People With Disabling Foot Pain
Karen J. Mickle et al.
ARTHRITIS CARE & RESEARCH (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Naomi Schlesinger et al.
ARTHRITIS RESEARCH & THERAPY (2011)
High Versus Low Dosing of Oral Colchicine for Early Acute Gout Flare Twenty-Four-Hour Outcome of the First Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Comparison Colchicine Study
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
A prescription for lifestyle change in patients with hyperuricemia and gout
Hyon K. Choi
CURRENT OPINION IN RHEUMATOLOGY (2010)
Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome
Ioannis Mitroulis et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis
R. Torres et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Resident Macrophages Initiating and Driving Inflammation in a Monosodium Urate Monohydrate Crystal-Induced Murine Peritoneal Model of Acute Gout
William John Martin et al.
ARTHRITIS AND RHEUMATISM (2009)
Use of imaging to evaluate gout and other crystal deposition disorders
Nicola Dalbeth et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
Michael A. Becker et al.
JOURNAL OF RHEUMATOLOGY (2009)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
N. Dalbeth et al.
RHEUMATOLOGY (2009)
PEG-uricase in the management Of treatment-resistant gout and hyperuricemia
Merry R. Sherman et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout - Results of a phase II randomized study
John S. Sundy et al.
ARTHRITIS AND RHEUMATISM (2008)
Resolution of gouty tophi after twelve weeks of pegloticase treatment
Herbert S. B. Baraf et al.
ARTHRITIS AND RHEUMATISM (2008)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
Naohiko Anzai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Urate transport across the apical membrane of renal proximal tubules
Hitoshi Endou et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
The changing epidemiology of gout
Edward Roddy et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study
Stephen A. Wright et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout
John S. Sundy et al.
ARTHRITIS AND RHEUMATISM (2007)
Inflammatory caspases: Targets for novel therapies
Sigrid Cornelis et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals
Peter Scott et al.
JOURNAL OF IMMUNOLOGY (2006)
EULAR evidence based recommendations for gout.: Part I:: Diagnosis.: Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
Chun-Jen Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation
LB Ru et al.
ARTHRITIS AND RHEUMATISM (2005)
Alcohol intake and risk of incident gout in men: a prospective study
HK Choi et al.
LANCET (2004)
New standards for uric acid excretion and evidence for an inducible transporter
PA Simkin
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
A literature review of the epidemiology and treatment of acute gout
KY Kim et al.
CLINICAL THERAPEUTICS (2003)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels
A Enomoto et al.
NATURE (2002)
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
G Würzner et al.
JOURNAL OF HYPERTENSION (2001)
Colchicine induced rhabdomyolysis
I Chattopadhyay et al.
POSTGRADUATE MEDICAL JOURNAL (2001)
Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts
F Perez-Ruiz et al.
NEPHRON (2000)
Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study
PH Dessein et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Share Paper
